Surgical treatments for acromegaly both by transnasal transsphenoidal cryogenic abla tion and by transsphenoidal microsurgical dissection were carried out in two different series and the postoperative follow-up results of HGH level and other pituitary hormones of both groups were compared and discussed for the first time. There were no significant differences in postoperative changes of pituitary functions between each operative method, whereas as for long-term satisfactory lowering of HGH level, i.e. radical cure of acromegaly, the microsurgical treatment was concluded as more reliable than cryogenic ablation of pituitary adenomas.
Introduction
Acromegaly is caused by hypersecretion of human growth hormone (HGH) from the functioning pituitary adenomas. It is obvious, therefore, that the treatment of this disease should be the complete removal or eradication of the pituitary tumor. The authors performed operations for acromegaly both by transnasal, transsphenoidal cryogenic surgery and by transsphenoidal microsurgery in two different series. Long-term follow-up study encompass ing 19 patients (9 patients by cryosurgery and 10 by microsurgery) whose clinical and endo crinological data, such as an assessment of perioperative change in HGH or other pituitary hormones, were available.
There is still some controversial opinions concerning the effectiveness of reduction in HGH, subsequent preservation of normal function of the pituitary gland, and operative complications, 22) between these two operative methods.
Detailed reports which concern postoperative follow-up evaluation of HGH and other Tables 1  and 2 .
Nine patients were available for clinical and endocrinological follow-up whose surgical in tervention was performed at the Department of Neurosurgery, Kyoto University Hospital since 1967. In cases of this series, the suprasellar extension of the tumor was rare or minimum even when it existed. Age of the patients ranged from 25 to 52 years and males outnumbered female by 8 to 1. All patients showed decreased sexual libido and one female was amenorrheal before surgery.
Preoperative fasting HGH levels ranged from 20.0 to 288.0 ng/ml (average 91.9 ng/ml) and all the cases showed no or abnormal responses of HGH to glucose tolerance test (GTT) and insulin tolerance test (ITT), except for 2 cases who showed partly normal responses (Cases 5 and 7). Preoperative pituitary functions were all in the normal range except for one who revealed slightly reduced values (Case 9).
Postoperative follow-up periods were between 1 and 6 years (average 26 months). Almost all the patients had clinical reversal of their acro megalic state after the surgery but postoperative HGH levels were varied between 4.8 and 42.6 ng/ml during follow-up periods. In 3 cases, HGH level was less than 5 ng/ml, in 2 cases, between 5 and 10 ng/ml and in the remaining 4 cases, more than 10 ng/ml in follow-up results. Two of 4 cases whose HGH level was still high one year after the surgery rejected re-cryoabla tion since their clinical manifestations improved. Three cases out of 9 showed a drop in HGH level to less than 10 ng/ml within a week but in 2 cases HGH level was gradually lowered after the surgery. The longest interval was about 5 years ( Fig. 1) . None of the cases showed normal responses to GTT or ITT, except for 2 cases (Cases 3 and 5) who displayed partly normal responses. Postoperative pituitary functions were preserved in 6 cases, became slightly re duced in 2 cases, and remained slightly reduced in one case (Case 9) even after the surgery. In the female case (Case 8), menses returned 2 months after the surgery. Transient diabetes insipidus occurred in 3 cases and severe epistaxis in one case. One case (Case 1) recurred about 5 years after surgery. Brief review of recurred case after cryosurgery This case who recurred after cryosurgery was a 38-year-old male and his preoperative HGH value was 80 ng/ml. His gonadotropins were all moderately hyperactive, but ACTH and Su 4885 tests as well as his thyroid functions were both normal. His fasting blood sugar (FBS) was 128 mg/dl and it exhibited a diabetic pattern to GTT. Cryoablation was performed by a routine method at two different sites in the sella. Histology of the tumor revealed an eosino philic adenoma. Postoperatively, HGH level rapidly dropped to 11.0 ng/ml and when he was re-examined one year after the operation, it remained still slightly higher than 10 ng/ml. His physical manifestations demonstrated much improvement after the surgery and other pitu itary functions were all in the normal range. Although he still had slightly elevated FBS, he was not followed up for 5 years. When he visited us again with symptoms of diabetic retinopathy, his FBS was 171 mg/dl and his HGH level had risen to 48.2 ng/ml. He was then operated on by microsurgery 6 years after the first operation. The residual tumor appeared mostly to be jellyish, well circumscribed and was totally removed except for a small part which was very fiberous and attached to the dura. His HGH level again dropped to 11.0 ng/ml after the surgery and remained at the same level for 3 years. He is still slightly diabetic but his condi tion is controllable. HGH values decreased to less than 5 ng/ml, and in 2 cases, they dropped to between 5 and 10 ng/ml.
B) Oronasal rhinoseptal transsphenoidal micro dissection
The overall results are summarized in Tables 3  and 4 . Clinical and endocrinological data for 10 out of 12 patients for whom surgery was per formed at the Department of Neurosurgery at Tenri Hospital since 1967 were available for follow-up. Ages ranged from 14 to 56 years and there were 4 male and 6 female cases. All of the patients exhibited clinical and radiological manifestations of acromegaly, but no supra sellar extensions of the tumor were recognized in this series, except for 2 cases who showed minimum suprasellar extension of the mass. One case included in this series is the same patient who relapsed 5 to 6 years after cryogenic sur gery. Five were diabetic and all 6 females were amenorrheal preoperatively.
Preoperative HGH levels ranged from 12.0 to 180.0 ng/ml with a mean value of 71.7 ng/ml and none of the cases showed normal responses to GTT or ITT, except for 2 cases who showed partly normal responses (Cases 3 and 7).
Preoperative pituitary functions were all in the normal range, except for one who displayed partial hyperactivities (Case 3, whose tumor was also gigantic). Postoperative follow-up periods varied be tween 3 months and 7 years (average 52 months). Clinical remissions were noted in all the cases, except for one (Case 8) and post operative HGH levels ranged from 2.4 to 36.4 ng/ml during the follow-up periods. In 4 cases, HGH level dropped to less than 5 ng/ml. In another 4 cases, it was between 5 and 10 ng/ml and in the remaining 2 cases, HGH level was more than 10 ng/ml. Four cases out of 10 revealed immediate postoperative drop in HGH level to less than 10 ng/ml. In another 4 cases, HGH value gradually decreased to less than 10 ng/ml within a couple of months, except for one in whom it took about 5 years (Fig. 2) . All the cases did not respond normally to GTT or ITT, except for one with microadenoma (Case 7) who showed partly normal response even preoperatively.
Postoperative pituitary functions were pre served in 4 cases, partially but slightly reduced in one (Case 8), and totally but slightly reduced in 5 cases, although 2 cases of these (Cases, 2 and 3) were gradually restored to normal during the follow-up periods. One female case with micro adenoma had menses again one year after the operation (Case 7). Three cases were still slightly diabetic but they were all controllable. Transi ent diabetes insipidus developed in 2 cases and one case (Case 6) died of meningitis 3 months after the surgery.' 2,23,24) Brief review of the non-curable case after micro surgery Case 8 was a 26-year-old female') who was amenorrheal and slightly diabetic (FBS was 131 mg/dl). Her preoperative HGH level was 165 ng/ml and was poorly responsive to ITT but not responsive to GTT. Her HGH level was elevated after administration of both LHrH and TRH. She had a ballooned sella with minimum suprasellar extension of the tumor verified by pneumoencephalogram. Angiogram revealed that bilateral carotid arteries were deviated medially into the sella on antero-posterior pro jection." °) At surgery, evacuation of the tumor was incomplete, since portions of the tumor behind the carotid arteries remained unresected. Portions which extended suprasellarly were completely removed. Histology of the tumor was acidophilic adenoma. Postoperative HGH value was still around 17.4-27.3 ng/ml, also poorly responsive to ITT, but not to GTT, and again it was responsive to both LHrH and TRH. Her pituitary functions remained un changed. After she received radiation therapy (4400 rads), her HGH level decreased transi ently to less than 10 ng/ml but rose again within a couple of months and her FBS also rose to 152 mg/dl. About one year after the first opera tion, a second exploratory operation was con templated to remove possibly remaining tumor and, at the surgery, tumor-like tissues behind both carotid arteries were well cleaned out. Her HGH level, however, was still higher than normal level after the surgery and always fluc tuated between 16-49.4 ng/ml for more than 3 years. Other pituitary functions all remained unchanged except for slight reduction in LH and FSH and she is still amenorrheal. HGH levels decreased to less than 5 ng/ml, and in 4 cases, they dropped to between 5 and 10 ng/ml. ions of Derome5) and Leavens et al.") con cerning the estimation of postoperative HGH level. They state that "cure" is when the level of HGH, as a basal or 60 minutes after hyper glycemia, is less than 5 ng/ml. "Failure" is more than 10 ng/ml and "intermediate" is between 5 and 10 ng/ml. According to their opinions, it is not certain whether treatment is complete or not when the HGH values are higher than 5 ng/ml after the operation. As mentioned in the results of cryosurgery, 3 cases were cured, 2 cases were intermediate and 4 cases were non-effective. Whereas in microsurgery, 4 cases were cured, 4 cases were intermediate and 2 cases were not cured. When we reviewed our results using the two surgical methods, estimating postoperative HGH level similar to Derome's method, the outcome of operations were more satisfactory in the microsurgery group than in the cryosurgery group. By microsurgery, we have better chances of removing the tumor tissue totally under the aid of an operative microscope and occasionally, we are also able to remove the intrapituitary microadenoma selectively whose complete resec tion promises satisfactory reduction of HGH without damaging normal pituitary functions.
Discussion
On the contrary, by cryogenic surgery, we cannot thoroughly estimate the ensuing freezing effect of the pathological tissue, although we can examine the size or extension of the lesion made by deep freezing.',") We are also yet not sure whether or not intrapituitary adenoma can be selectively frozen by this method. 19) Ac cordingly, as far as satisfactory reduction of postoperative HGH value is concerned, micro surgical dissection of the tumor can be said to be a more accurate and steady method. Accord ing to the foregoing reports, postoperative changes in HGH is much faster after micro surgical intervention while, on the other hand, with cryogenic surgery the postoperative drop in HGH is sometimes gradual or delayed.") As for the postoperative interval for reducing the HGH below the normal level, our studies showed that there were no significant differ ences between the two operative groups as almost half of the operated cases showed instant drop in HGH in each group.
Recurrent case and incurable case as judged by postoperative HGH levels We experienced one case of recurrence (Case 1) in the cryogenic surgery group. Postoperatively, his HGH level was 11.0 ng/ml when examined immediately after and one year after the surgery. He was not followed up further, and recurrent elevation of HGH was observed about 5 years after the first operation. The authors believe that Derome's method of estimating postopera tive value of HGH is accurate since this patient showed only a slightly higher HGH level than the "intermediate" level (11 ng/ml) for one year after the operation. According to Liidecke et al. 18) , recurrence occurs frequently during the first year after the operation, but we do not know the exact time our case really recurred. This case suggests that the postoperative value of HGH should be frequently followed up for a longer period in all cases whose HGH level was still higher than 5 ng/ml after the destructive proce dure for the tumor tissue was taken.
We had one uncured case by microsurgery (Case 8). We believed that her postoperative HGH value which was higher than normal was perhaps due to a residual tumor behind the intrasellarly protruding carotid arteries, since we were able to completely remove only the other parts of the tumor. When we operated again one year later following irradiation, we found her intrasellar cavity to be surprisingly clear, and the remaining tissue behind the carotid arteries was verified as histologically non tumorous.27) Postoperative HGH value was, however, unsatisfactory and elevated again by administration of both LHrH and TRH al though stimulation of HGH secretion by LHrH was denied in female by Rubin et al. 25 ) It was strange, however, that her other pituitary func tions all remained normal even after two opera tions and irradiation except for slight reduction in basal LH and FSH values which were reactive to LHrH stimulation. Since her HGH value was always fluctuating above the normal level and rose persistently after administration of both LHrH and TRH, her operative results might indicate either the presence of residual tumor cells left behind, possibly outside of the cellar cavity, or abnormal response of the remaining HGH-producing tissue, but we have no clear cut explanation for that.' 5,26,28) Preservation of normal pituitary functions In the surgery of acromegaly, the reduction of HGH value is usually manageable but preserva tion of normal pituitary function is more prob lematic. It is always mandatory to remove the tumor completely and evacuate the sellar cavity without sacrificing recognizable anterior pitui tary. It is surprising, however, that postopera tive hypopituitarism was not so severe or some times partial even after presumably total resec tion of all anterior pituitary. Considerably normal function was retained with satisfactory reduction of HGH level and, additionally, in sufficient pituitary functions gradually returned to normal in the follow-up periods in some cases probably due to regeneration of normal pitui tary tissue .4,19) As for the preservation of normal pituitary function, Li decke et al. 18) reported that in almost half of their cases, adenohypophyseal function was retained in "indistinct" operations . Also in 27% of their cases, active pituitary function was found even after "non-selective" radical excision. This con firms the hypothesis that complete removal of anterior pituitary can rarely be achieved during surgery since normal pituitary is compressed to the periphery of the sella by the tumor itself") cryogenic surgery, and if we perform "com plete" total evacuation of the cellar cavity in microsurgery.
Complications
There were no significant differences in the inci dences of operative complications in each opera tive method. These complications were not problematic except for one case who had a history of chronic sinusitis preoperatively and died of meningitis after microsurgical operation.
Conclusion
After eradication of secreting pituitary adenoma either by cryogenic surgery or by microsurgical intervention, the patients usually have satisfac tory clinical remissions. There are, however, little correlations between HGH levels and clinical activity. The authors believe it appro priate to use severe criterias for estimating post operative HGH levels according to Derome's method.') When estimating our follow-up data of HGH in each method, the microsurgical in tervention is more steady and satisfactory in lowering HGH level than cryogenic surgery. As for the postoperative preservation of normal pituitary functions, there are no definite dif ferences between these operative methods. Using the microsurgical technique, it is much more feasible to remove intrapituitary adenoma selec tively, but conversely, with this technique, post operative hypopituitarism is likely to occur in case of "probably selective" resection of pitui tary tumor. Since postoperative hypopituitarism is not severe, and sometimes temporary, exoge nous hormone administration is required in a few cases. The authors believe that all dubious tissue should be resected together with the tumor tissue by microsurgical technique for complete cure of acromegaly. It is concluded that, as far as a radical treatment of acromegaly is concerned, the microsurgical resection is more preferable than cryogenic surgery for hyper secreting pituitary adenoma.
